Skip to content
Gold Mining News – Lifestyle
Author:
UTR Therapeutics Inc.
UTR Therapeutics Inc. Announces U.S. FDA Orphan Drug Designation and Rare Pediatric Disease Designation for UTRxMYCN M1-14
September 29, 2026